p16INK4A-CDK4/6-RB pathway
E1555606
UNEXPLORED
The p16INK4A-CDK4/6-RB pathway is a key cell cycle regulatory cascade that controls the G1-to-S phase transition and acts as a critical tumor suppressor mechanism frequently dysregulated in cancer.
All labels observed (1)
| Label | Occurrences |
|---|---|
| p16INK4A-CDK4/6-RB pathway canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22796768 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: p16INK4A-CDK4/6-RB pathway Context triple: [CDK6, belongsToPathway, p16INK4A-CDK4/6-RB pathway]
-
A.
CDKN2A (p16INK4A)
CDKN2A (p16INK4A) is a tumor suppressor gene encoding a cyclin-dependent kinase inhibitor that controls cell cycle progression and is frequently inactivated in human cancers.
-
B.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
C.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
D.
cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
-
E.
CDKN2B (p15INK4B)
CDKN2B (p15INK4B) is a cyclin-dependent kinase inhibitor tumor suppressor protein that controls cell cycle progression by inhibiting CDK4/6 activity.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: p16INK4A-CDK4/6-RB pathway Target entity description: The p16INK4A-CDK4/6-RB pathway is a key cell cycle regulatory cascade that controls the G1-to-S phase transition and acts as a critical tumor suppressor mechanism frequently dysregulated in cancer.
-
A.
CDKN2A (p16INK4A)
CDKN2A (p16INK4A) is a tumor suppressor gene encoding a cyclin-dependent kinase inhibitor that controls cell cycle progression and is frequently inactivated in human cancers.
-
B.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
C.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
D.
cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
-
E.
CDKN2B (p15INK4B)
CDKN2B (p15INK4B) is a cyclin-dependent kinase inhibitor tumor suppressor protein that controls cell cycle progression by inhibiting CDK4/6 activity.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.